Free Trial

Best Penny Stocks Under 10 Cents Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.10 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.10.

Aclarion stock logo

#1 - Aclarion

NASDAQ:ACON
Stock Price:
$0.04 (-$0.02)
Market Cap:
$1.27 million
Average Trading Volume:
133.14 million shares
Consensus Rating:
Moderate Buy (1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.30 (3,303.1% Upside)
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
CNS Pharmaceuticals stock logo

#2 - CNS Pharmaceuticals

NASDAQ:CNSP
Stock Price:
$0.10 (-$0.01)
P/E Ratio:
0.00
Market Cap:
$5.73 million
Average Trading Volume:
38.83 million shares
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$0.50 (401.5% Upside)
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.
Eyenovia stock logo

#3 - Eyenovia

NASDAQ:EYEN
Stock Price:
$0.06 (+$0.00)
P/E Ratio:
-0.08
Market Cap:
$6.51 million
Average Trading Volume:
31.10 million shares
Consensus Rating:
Hold (0 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$2.00 (3,324.7% Upside)
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
Vincerx Pharma stock logo

#4 - Vincerx Pharma

NASDAQ:VINC
Stock Price:
$0.10 (-$0.00)
P/E Ratio:
-0.10
Market Cap:
$3.35 million
Average Trading Volume:
4.64 million shares
Consensus Rating:
Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$2.00 (1,912.1% Upside)
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

#5 - Cannabist

OTCMKTS:CBSTF
Stock Price:
$0.06 (-$0.00)
Average Trading Volume:
765,266 shares
Consensus Rating:
Moderate Buy (1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$0.75 (1,251.4% Upside)
The Cannabist Company Holdings Inc. engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. The company provides flower, concentrates, edibles, and/or accesories, and medicinal cannabinoid capsules and tablets, as well as confections, chocolate, drink mixes, condiments, kief, shatter, and wax/crumble, under the Seed & Strain, Classix, and Triple Seven brand names. It offers management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in New York, New York.
Nextech3D.AI stock logo

#6 - Nextech3D.AI

OTCMKTS:NEXCF
Stock Price:
$0.05 (-$0.01)
Market Cap:
$6.56 million
Average Trading Volume:
552,708 shares
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$0.25 (447.0% Upside)
Nextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. The company was formerly known as NexTech AR Solutions Corp. and changed its name to Nextech3D.AI Corporation in September 2023. Nextech3D.AI Corporation was incorporated in 2018 and is headquartered in Toronto, Canada.
BIOLASE stock logo

#7 - BIOLASE

NASDAQ:BIOL
Stock Price:
$0.01 (-$0.00)
P/E Ratio:
0.00
Market Cap:
$291,000.00
Average Trading Volume:
2.58 million shares
Consensus Rating:
Moderate Buy (2 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.20 (13,693.1% Upside)
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Exro Technologies stock logo

#8 - Exro Technologies

OTCMKTS:EXROF
Stock Price:
$0.08 (-$0.00)
P/E Ratio:
-0.17
Market Cap:
$44.79 million
Average Trading Volume:
238,333 shares
Consensus Rating:
Hold (0 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Exro Technologies Inc. focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. It also provides electric vehicle consulting and engineering services. The company was incorporated in 2014 and is headquartered in Calgary, Canada.
Loop Media stock logo

#9 - Loop Media

NYSEAMERICAN:LPTV
Stock Price:
$0.06 (-$0.00)
P/E Ratio:
-0.17
Market Cap:
$4.65 million
Average Trading Volume:
194,128 shares
Consensus Rating:
Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.00 (1,685.7% Upside)
Loop Media, Inc. operates as a multichannel digital video platform media company in the United States. The company offers hand-curated music video content licensed from major and independent record labels, including Universal Music Group, Sony Music Entertainment, and Warner Music Group; and non-music video content, which is licensed or acquired from third parties, such as action sports clips, drone and atmospheric footage, trivia, news headlines, lifestyle channels, and kid-friendly videos, as well as movie, television and video game trailers, and other content. It distributes its content and advertising inventory to digital screens located in out-of-home (OOH) locations primarily through its owned and operated platform (the O&O Platform) of Loop Media-designed small-box streaming Android media players and legacy Screenplay computers; and screens on digital platforms owned and operated by third parties. The company is headquartered in Burbank, California.
Golden Minerals stock logo

#10 - Golden Minerals

NYSE:AUMN
Stock Price:
$0.09 (+$0.00)
P/E Ratio:
-0.16
Market Cap:
$1.28 million
Average Trading Volume:
67,992 shares
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.50 (1,660.6% Upside)
Golden Minerals Company, a precious metals exploration company explores for mineral properties in Argentina, Nevada, and Mexico. It explores for gold, silver, copper, zinc, lead, and other minerals. The company was formerly known as Apex Silver Mines Limited and changed its name to Golden Minerals Company in March 2009. Golden Minerals Company was founded in 1996 and is headquartered in Golden, Colorado.
SpringBig stock logo

#11 - SpringBig

NASDAQ:SBIG
Stock Price:
$0.06 (-$0.00)
P/E Ratio:
-0.72
Market Cap:
$2.79 million
Average Trading Volume:
91,349 shares
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.00 (1,639.1% Upside)
SpringBig Holdings, Inc. develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada. Its platform offers customer loyalty and marketing automation solutions. The company was founded in 2016 and is headquartered in Boca Raton, Florida.
Zapata Computing stock logo

#12 - Zapata Computing

NASDAQ:ZPTA
Stock Price:
$0.00 (+$0.00)
Market Cap:
$155,000.00
Average Trading Volume:
858,261 shares
Consensus Rating:
Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$1.63 (40,525.0% Upside)
Zapata Computing Holdings Inc. operates as an industrial generative artificial intelligence (AI) software company in the United States. The company offers subscription-based solutions that combine software and services to develop generative AI applications, as well as accompanying services to solve complex industrial problems. It also provides Zapata AI Sense, a suite of algorithms and complex mathematical models to enhance analytics and other data-driven applications; Zapata AI Prose, a set of generative AI solutions based on large language models for generic chatbot applications; and Orquestra, an industrial generative AI application development platform, which provides sense and prose. It serves enterprise organizations. Zapata Computing Holdings Inc. was founded in 2017 and is based in Boston, Massachusetts.
MetaWorks Platforms stock logo

#13 - MetaWorks Platforms

OTCMKTS:MWRK
Stock Price:
$0.01 (-$0.00)
P/E Ratio:
-0.08
Market Cap:
$613,000.00
Average Trading Volume:
226,363 shares
Consensus Rating:
Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
MetaWorks Platforms, Inc. provides blockchain and Web3 development platform. It offers turnkey set of services for companies to develop and integrate blockchain and cryptocurrency technologies into their business operations. The company provides business development and technical services; blockchain and technology program management services; customer development services; business launch services; and post-business launch support services. The company was formerly known as CurrencyWorks Inc. and changed its name to MetaWorks Platforms, Inc. in August 2022. MetaWorks Platforms, Inc. was incorporated in 2010 and is based in Fairfield, California.
Corus Entertainment stock logo

#14 - Corus Entertainment

OTCMKTS:CJREF
Stock Price:
$0.07 (-$0.00)
P/E Ratio:
-0.02
Market Cap:
$13.76 million
Average Trading Volume:
19,439 shares
Consensus Rating:
Sell (0 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings)
Consensus Price Target:
N/A
Corus Entertainment Inc., a media and content company, operates specialty and conventional television networks, and radio stations in Canada and internationally. It operates in two segments, Television and Radio. The Television segment consists of specialty television networks, conventional television stations, digital and streaming platforms, a social digital agency, and a social media creator network; and provides technology and media services. This segment also engages in the production and distribution of films and television programs; merchandise licensing and book publishing activities; and provision of advertising services, subscriptions, and the licensing of proprietary films and television programs, as well as production services. The Radio segment operates radio stations that include a network of news/talk radio stations, as well as classic hits, rock, country, and hot adult contemporary radio formats. The company produces and distributes children's animated content and consumer products; owns Nelvana, Corus Studios, Aircraft Pictures, Kid Can Press, so.da, and Kin Community Canada, and Quay Media Services; and operates companion websites, digital and streaming platforms, and applications that are related to its brands. Corus Entertainment Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.
Yield10 Bioscience stock logo

#15 - Yield10 Bioscience

NASDAQ:YTEN
Stock Price:
$0.00
P/E Ratio:
0.00
Market Cap:
$1,000.00
Average Trading Volume:
78,164 shares
Consensus Rating:
Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Mondee stock logo

#16 - Mondee

NASDAQ:MOND
Stock Price:
$0.00 (-$0.00)
P/E Ratio:
0.00
Market Cap:
$437,000.00
Average Trading Volume:
1.16 million shares
Consensus Rating:
Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$3.83 (3,833,233.3% Upside)
Mondee Holdings, Inc. operates as a travel technology company in the leisure and corporate travel markets in the United States and internationally. The company operates through two segments, Travel Marketplace and SaaS Platform. The Travel Marketplace segment primarily engages in sale of airline tickets through its platform. The SAAS Platform segment offers corporate travel cost savings solutions through its technology platform. The company connects a network of leisure travel and gig economy workers, vacation homes, hotels, packaged solutions, and ancillary offerings. The company was founded in 2011 and is headquartered in Austin, Texas.

#17 - Medicine Man Technologies

OTCMKTS:SHWZ
Stock Price:
$0.02 (-$0.02)
Average Trading Volume:
5,029 shares
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$2.50 (12,400.0% Upside)
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
TFF Pharmaceuticals stock logo

#18 - TFF Pharmaceuticals

NASDAQ:TFFP
Stock Price:
$0.07
P/E Ratio:
-0.01
Market Cap:
$289,000.00
Consensus Rating:
Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
$44.00 (67,592.3% Upside)
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas.

More Stock Ideas from MarketBeat